Elite Research USA

Quality | Trust | Service

[Elite Research USA @EliteresearchUS]

Vilon https://t.co/aZtQK1hfsp https://t.co/RjDgc0WbjS

[Jamal Dinkoui @BerbarianWizard]

Vilon was tested in a Russian 2006 paper on hypogonadal / aging-model male rats.

Protocol: 50 µg Vilon per rat, intraperitoneally, for 18 days.

After Vilon, sexual behavior improved strongly:

- Mounts: +42%
- First-session intromissions: +59.2%
- Total intromissions: +75.1%
- Ejaculations: +31.3%
- Intromission latency: −35.2%
- Inter-ejaculatory interval: −12.3%
- First mount latency: −24%
- Recovery period after ejaculation: −14%

The endocrine changes were also interesting:

- LH: 18-fold increase
- Prolactin: −30.5%, basically back toward control
- ACTH: +168%

Hypothalamic neurotransmitters shifted too:

- Noradrenaline: −63%
- Serotonin: −39%
- Dopamine: normalized

PMID: 17152729

[Elite Research USA @EliteresearchUS]

Russia gave us gifts to change mankind🚀

**For Research**

[THE REAL 💯D👀KS💯 @trinity2pointO]

I am dragging ass this morning like mfer. Thankfully I have something for that at the office.

[Elite Research USA @EliteresearchUS]

Sodium caprate*

[Elite Research USA @EliteresearchUS]

I will be releasing articles on these (oral Epitalon and Pinealon) very soon… in addition to the benefits, we use enteric coated capsules AND we use SNAC as a filler to increase the absorption https://t.co/ZM8hfio8Sb

[Ryan Christensen @belief_engineer]

Folks - here's my article talking about the results I've had using @EliteresearchUS's Pinealon for two weeks.

Short version - almost all of the cognitive decline I've experienced due to my bipolar disorder has been recovered or reversed.

In 14 days.

This isn't just hype - I have the EXG / EEG brainwave scans to prove it.

It's a beefy article (over 3,000 words) but I wanted to give as much context and explanation as I could given the results I've seen.

I haven't seen any n=1 Pinealon experiments that included brainwave measurements, so this might be a first of it's kind.

[Elite Research USA @EliteresearchUS]

In short, the combination of these research compounds could theoretically provide…

•Complementary mitochondrial action - J-147 optimizes existing mitochondria via ATP synthase modulation; PQQ builds new ones via PGC-1 alpha–driven biogenesis
•Combined energy effect - cleaner ATP output per mitochondrion plus a larger total mitochondrial pool
•Shared NGF signaling - both compounds independently stimulate nerve growth factor, reinforcing neuron maintenance and survival
•Added BDNF support - J-147 additionally elevates BDNF, driving synaptogenesis and neurogenesis alongside PQQ’s NGF effect
•Layered antioxidant protection - PQQ’s redox cycling shields mitochondria from oxidative stress while J-147 reduces neuroinflammatory markers
•Non-stimulant cognitive support - J-147’s mild anxiolytic profile plus PQQ’s mitochondrial efficiency support focus without stimulant-driven arousal
•Net effect - a mechanistically complementary stack supporting energy capacity, neuroprotection, and neurotrophic signaling from multiple angles simultaneously

[Elite Research USA @EliteresearchUS]

Many of you must not know about the benefits of our new Genesis product which combines J-147 with PQQ… I’m surprised it hasn’t sold out yet.

J-147 is a synthetic curcumin derivative, engineered specifically to retain curcumin’s neuroprotective properties while achieving the blood-brain barrier penetration curcumin lacks. Its molecular target is mitochondrial ATP synthase, the enzyme complex responsible for the final step of oxidative phosphorylation. Through it’s modulation of ATP5A, J-147 alters mitochondrial energetics in a way that increases intracellular calcium and activates the CAMKK2-AMPK signaling axis, a pathway strongly associated with cellular energy homeostasis and longevity signaling. This mechanism also intersects with acetyl-CoA metabolism, influencing the substrate pool that governs both energy production and neuroprotective acetylation signaling in neural tissue.

Downstream of these effects, preclinical studies have demonstrated that J-147 elevates both nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF). NGF supports the maintenance and survival of existing neurons. BDNF drives synaptogenesis, dendritic growth and hippocampal neurogenesis (structural substrates of memory formation and cognitive flexibility). The simultaneous elevation of both neurotrophins is uncommon among small molecules and represents one of J-147’s most distinctive pharmacological features.

In addition, rodent studies have documented mild anxiolytic activity, meaning the compound’s support for neural energy metabolism is accompanied by a calming rather than stimulating behavioral profile.
In aged animal models, J-147 administration improved cognitive performance, restored markers of synaptic function and reduced markers of neuroinflammation and oxidative stress.

PQQ (pyrroloquinoline quinone) is a redox-active quinone cofactor that operates on a complementary axis: mitochondrial biogenesis. Its primary documented mechanism is activation of PGC-1 alpha, the transcriptional coactivator recognized as the master regulator of new mitochondrial formation. By upregulating PGC-1 alpha and CREB signaling, PQQ increases mitochondrial number and density, expanding a cell’s total capacity for ATP production rather than only optimizing existing output.

PQQ also protects the machinery of energy production itself, functioning as an exceptionally stable redox catalyst capable of completing thousands of oxidation-reduction cycles before degradation. This sustained catalytic activity neutralizes the reactive oxygen species generated as a byproduct of electron transport, shielding mitochondrial membranes and mitochondrial DNA from cumulative oxidative damage.

The net bioenergetic effect is a larger, better-protected mitochondrial network producing ATP more reliably under metabolic demand. Because neurons are among the most mitochondria-dense and energy-hungry cells in the body, these effects translate directly into the nootropic domain. In vitro research has demonstrated that PQQ stimulates the synthesis and secretion of nerve growth factor (NGF), a neurotrophin essential for the survival and maintenance of cholinergic neurons involved in learning and memory. Human trials have associated PQQ supplementation with measurable improvements in attention, working memory, and processing speed, with the most consistent effects observed in middle-aged and older adults.

[Elite Research USA @EliteresearchUS]

https://t.co/HGJm7sxXvV

[SilverFoxLeo @BowTiedHRT]

O-304 is well worth watching closely.

O-304 is an orally administered pan-AMPK activator. It’s a small molecule developed by Betagenon/Baltic Bio and is currently in Phase IIa human trials.

0-304 turns on AMPK (the enzyme system that governs how your cells manage energy) directly, without requiring the body to be in a fasted state or subjected to a hard training session.

On paper it means more glucose pulled into muscle, more fat oxidized for fuel, more mitochondrial biogenesis, and less glucose dumped by the liver.

0-304 is essentially an exercise mimetic that promises the metabolic upside of exercise through pharmacological magic 🪄

I have no personal or client experience with this one so I’m flagging it as extremely promising, but I’m not flat out recommending it. Yet.

The mechanism is sound and it is further along in trials than most research compounds ever get which says a lot.

0-304 is well worth tracking as it moves through the trial pipeline and it’s next on my list to try out as soon as the weather breaks cooler and I can get back to my regularly scheduled psychotic outdoor cardio routine.

Direct link below ⬇️

[Elite Research USA @EliteresearchUS]

Cooking new formulas…

[Elite Research USA @EliteresearchUS]

@fitcapgirldad Have this one sitting on my dash!

[Elite Research USA @EliteresearchUS]

We finally did it... we made an X account! We'll be sharing educational content, cutting edge industry insights and exclusive products here. Follow us so you don't get left behind.